Cholinergic signaling in immune cells appears to regulate cytokine synthesis, influencing both the initiation and termination of inflammation (e.g., IL-2 in T cells, TNF in macrophages, and IL-8 in dendritic cells)
Even in obese individuals without T2DM, it has proven its value, showing reduced energy intake and body weight while improving blood sugar levels
Semaglutide: 1st approved drug for adult weight management, targeting general obesity or overweight
This results in two main outcomes
Moreover, HbA1c levels decreased from 39.3 to 36.6, indicating better glycemic control, while average CRP levels fell from 7.8 to 6.9, signifying reduced inflammation
Monitor your blood sugar levels closely if you have diabetes